CervixCheck is exploring options to improve cervix screening rates in the underscreened by use of a digital platform providing women the opportunity to self-collect of samples for HPV-based testing for cervix screening. Pilot project currently being rolled out in the Fraser Health region, w
This project aims to discover new markers of breast cancer through an international effort focused on low-penetrance alleles that, in combination, have a high probability of explaining a large proportion of breast cancer risk.
Multiple Myeloma (MM) is generally incurable and patients will eventually develop relapsed/refractory disease. Early relapse is associated with poor clinical outcomes and overall survival.
As a co-investigator on this project and leader of the GE3LS research activities, Dr. Regier leads the health economics activities of the LSARP project.
The Silent Genomes project aims to elucidate and address the health inequities faced by Canadian Indigenous populations when accessing genomic technologies for the diagnosis of genetic diseases.
Dr. Regier’s GeneSolve study, recently funded by Genome British Columbia, examines the value of genomic sequencing for diagnosing childhood rare diseases.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.